Patents by Inventor Juergen Reess

Juergen Reess has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of type 2 diabetes
    Patent number: 8202884
    Abstract: The invention relates to the use of a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof for the manufacture of a medicament for the treatment of diabetic patients.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: June 19, 2012
    Assignee: Neurosearch A/S
    Inventors: Klaus Dugi, Andreas Raschig, Juergen Reess, Frank Berger, Laurence Salin
  • PHARMACEUTICAL COMPOSITION COMPRISING A MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITOR AND AN ACETYLCHOLINESTERASE INHIBITOR
    Publication number: 20100210626
    Abstract: The invention relates to a pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof (1), and at least one acetylcholinesterase inhibitor or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof (2), and a pharmaceutically acceptable carrier or excipient, and optionally one or more other therapeutic ingredients.
    Type: Application
    Filed: April 27, 2010
    Publication date: August 19, 2010
    Inventors: Thomas FRIEDL, Joachim MIERAU, Andreas RASCHIG, Juergen REESS, Joergen SCHEEL-KRUEGER
  • PHARMACEUTICAL FORMULATION COMPRISING PRAMIPEXOLE
    Publication number: 20100168191
    Abstract: The present invention refers to the use of a medicament for the paediatric treatment of RLS and/or Tic Disorder and/or Tourette's Syndrom.
    Type: Application
    Filed: May 10, 2008
    Publication date: July 1, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Juergen Reess, Thomas Friedl, Nantharat Pearnchob
  • COMBINATION WITH AN EXTENDED RELEASE TABLET FORMULATION CONTAINING PRAMIPEXOLE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    Publication number: 20100092554
    Abstract: The present invention is directed to a combination of an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof with a conventional treatment option of Parkinson's Disease.
    Type: Application
    Filed: April 22, 2008
    Publication date: April 15, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Juergen Reess, Laurence Salin
  • METHODS FOR PREVENTING AND TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20100081625
    Abstract: The present invention relates to a method for treating, preventing or slowing, delaying or reversing progression of one or more neurodegenerative disorders in a patient in need thereof characterized by administering a glucopyranosyl-substituted benzene derivative, a tautomer, stereoisomer, mixture or salt thereof, as defined in claim 1 to the patient in need thereof.
    Type: Application
    Filed: January 25, 2008
    Publication date: April 1, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Marion Wienrich, Juergen Reess
  • Treatment of Diabetes
    Publication number: 20090018159
    Abstract: The invention relates to the use of a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof for the manufacture of a medicament for the treatment of diabetic patients.
    Type: Application
    Filed: October 31, 2006
    Publication date: January 15, 2009
    Applicant: NeuroSearch A/S
    Inventors: Klaus Dugi, Andreas Raschig, Juergen Reess, Frank Berger, Laurence Salin
  • Use of Pramipexole for Treating Moderate to Severe Restless Legs Syndrome (Rls)
    Publication number: 20080262053
    Abstract: The invention relates to the use of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzo-thiazole, the (+)- or (?)-enantiomer thereof or the pharmacologically acceptable salts thereof for treating moderate to severe Restless Legs Syndrome (RLS).
    Type: Application
    Filed: October 16, 2006
    Publication date: October 23, 2008
    Inventor: Juergen Reess
  • PRAMIPEXOLE FOR THE TREATMENT OF ADHD
    Publication number: 20080146628
    Abstract: A method for prevention and/or treatment of ADHD in a patient in need thereof, the method comprising administering to the patient an effective amount of 2-amino-4,5,6,7-tetrahydro-6-n-propylaminobenzothiazole or a pharmacologically acceptable acid addition salt, hydrate, or solvate thereof.
    Type: Application
    Filed: February 28, 2008
    Publication date: June 19, 2008
    Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
    Inventors: Juergen REESS, Franco BORSINI
  • Compounds for the sustained reduction of body weight
    Publication number: 20050203124
    Abstract: The invention relates to the use of a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof for a medicament for the for the sustained reduction of body weight.
    Type: Application
    Filed: January 21, 2005
    Publication date: September 15, 2005
    Applicants: Boehringer Ingelheim International GmbH, NeuroSearch A/S
    Inventors: Stephane Pollentier, Andreas Raschig, Juergen Reess, Ole Graff, Birgit Mikkelsen, Morten Priskorn
  • Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist
    Publication number: 20050182089
    Abstract: Accordingly, the invention relates to a pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof, and at least one NMDA receptor antagonists or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof.
    Type: Application
    Filed: January 21, 2005
    Publication date: August 18, 2005
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Thomas Friedl, Joachim Mierau, Andreas Raschig, Juergen Reess
  • Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
    Publication number: 20050154009
    Abstract: The invention relates to a pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof, and at least one acetylcholinesterase inhibitor or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof, and a pharmaceutically acceptable carrier or excipient, and optionally one or more other therapeutic ingredients.
    Type: Application
    Filed: October 15, 2004
    Publication date: July 14, 2005
    Applicants: Boehringer Ingelheim International GmbH, NeuroSearch A/S
    Inventors: Thomas Friedl, Joachim Mierau, Andreas Raschig, Juergen Reess, Joergen Scheel-Krueger
  • Pramipexole for the treatment ADHD
    Publication number: 20050049289
    Abstract: A method for prevention and/or treatment of ADHD in a patient in need thereof, the method comprising administering to the patient an effective amount of 2-amino-4,5,6,7-tetrahydro-6-n-propylaminobenzothiazole or a pharmacologically acceptable acid addition salt, hydrate, or solvate thereof
    Type: Application
    Filed: October 4, 2004
    Publication date: March 3, 2005
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Juergen Reess, Franco Borsini
  • Pramipexole for the reduction of excessive food intake for children
    Publication number: 20040266794
    Abstract: The invention relates to the use of dopamine receptor agonists for preparing a pharmaceutical composition for reducing excessive food intake.
    Type: Application
    Filed: March 16, 2004
    Publication date: December 30, 2004
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Joachim Mierau, Juergen Reess, Marion Wienrich
  • Pramipexole for the treatment of ADHD
    Publication number: 20030036555
    Abstract: A method for prevention and/or treatment of ADHD in a patient in need thereof, the method comprising administering to the patient an effective amount of 2-amino-4,5,6,7-tetrahydro-6-n-propylaminobenzothiazole or a pharmacologically acceptable acid addition salt, hydrate, or solvate thereof.
    Type: Application
    Filed: July 18, 2002
    Publication date: February 20, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Juergen Reess, Franco Borsini